Washington State University researchers have built a 3D-printed model of the left side of the heart that contracts and relaxes to simulate a real heartbeat, complete with embedded sensors and ultrasound compatibility. The model, developed by a team led by Kaiyan Qiu, the Berry Family Assistant Professor, is designed to give surgeons a more realistic, patient-specific practice tool before they operate on a living patient. If validated in larger studies, this kind of dynamic simulator could improve how clinicians rehearse some of the most complex cardiac procedures.
A Synthetic Heart That Beats and Bleeds
The WSU team’s model is not a static anatomical prop. It is a fully synthetic, scan-derived replica of the left heart, including the atrium, ventricle, and mitral valve, and it moves. As imitation blood is pumped through the system, sensors on the model monitor pressure in real time, according to Washington State University’s announcement and a corresponding EurekAlert release. The model also works under ultrasound imaging, allowing clinicians to visualize flow patterns and valve behavior just as they would during a live procedure. Qiu said the team’s layer-by-layer 3D-printing approach allows precise control over the model’s flexibility and dynamics, enabling the replica’s mechanical response to be tuned to better match cardiac tissue.
What makes this particular model stand out from earlier flexible heart replicas is its demonstrated clinical workflow. The team used the simulator to practice an edge-to-edge mitral valve repair, a procedure in which a clip is placed on the valve leaflets to reduce blood leaking backward through the heart. Integrated sensing allowed the researchers to quantify regurgitation before and after the simulated repair, giving them hard data on how well the fix worked rather than relying on visual estimates alone. That feedback loop, combining actuation, imaging, and measurement in a single benchtop system, is the core technical advance and hints at how future simulators might be evaluated not just on realism but on how well they support measurable decision-making during complex interventions.
How Earlier Models Set the Stage
Dynamic pulsatile heart simulators are not entirely new, but prior versions had narrower capabilities. Researchers have previously connected 3D-printed pediatric heart models to a closed-loop circulation rig for catheter training and imaging practice, demonstrating that compliant printed anatomy can withstand repeated pulsatile loading. Separately, a team published work on a 3D-printed flexible heart model designed as a reusable foundation for simulating multiple surgical scenarios, with detailed documentation of materials and workflow. These efforts proved that printed hearts could move and hold up to repeated use, but they generally lacked the integrated sensing, ultrasound-guided workflows, and repair-specific feedback that the WSU model now provides.
The most direct precursor came from MIT, where researchers built patient-specific soft robotic heart replicas that look and pump like the real organ. That work, published in Science Robotics, described an experimentally validated methodology for converting medical images into compliant printed anatomy coupled to controlled actuation; the MIT soft heart platform focused on modeling aortic stenosis and ventricular remodeling. By matching patient-specific flows and pressures, the MIT group showed that a 3D-printed, actuated beating heart can improve preprocedural planning and device testing. The WSU team’s contribution extends that principle to the mitral valve and adds embedded measurement, moving from primarily diagnostic modeling toward active surgical rehearsal, where a procedural strategy can be practiced and quantitatively refined before entering the operating room or catheterization lab.
Beyond Simulation: Printing Living Cardiac Tissue
While the WSU and MIT models are mechanical simulators, a parallel research track is pushing toward biologically active constructs that do more than mimic motion. The National Institute of Biomedical Imaging and Bioengineering has highlighted preclinical work in which printed cardiac tissue patches integrate with a beating heart, pointing the field toward functional biohybrid constructs. Related preclinical studies indexed in biomedical databases have explored how engineered tissue can be designed to regulate heart rhythm using light-responsive technology, blurring the line between a passive simulator and an active therapeutic implant. These studies are still early, but they show that 3D printing can organize cells and materials into structures that interact dynamically with native myocardium.
These two tracks, mechanical simulators and biological constructs, are beginning to converge conceptually. A mechanical model that faithfully reproduces patient-specific hemodynamics can serve as a test bed not only for surgical clips and catheters but also for experimental tissue patches or drug-eluting devices before they ever touch a patient. At the same time, insights from living constructs can inform how mechanical simulators represent tissue stiffness, electrophysiological behavior, or remodeling after an intervention. A growing body of cardiovascular 3D-printing literature, including a recent overview of clinical applications, reflects a field steadily building the evidence base needed to move these tools from academic labs into routine planning, training, and even hybrid therapeutic workflows.
What Still Stands Between the Lab and the Operating Room
The gap between a promising prototype and a device that changes surgical outcomes is wide, and most coverage of 3D-printed hearts glosses over it. No published data yet quantify how training on a dynamic printed heart simulator translates to lower complication rates, shorter procedure times, or reduced radiation exposure in real patients. The WSU paper demonstrates that the model can detect changes in regurgitation during a simulated repair, but whether that feedback reliably predicts outcomes in living tissue, where inflammation, scarring, arrhythmias, and patient-to-patient variability dominate, is an open question. To bridge that gap, researchers will need prospective studies that compare standard training with simulator-augmented training and track metrics such as procedural success, device repositioning rates, and learning curves for new operators over substantial case volumes.
Cost and logistics also remain largely unaddressed in the current literature. Producing a patient-specific, sensor-laden heart model for every complex mitral case would need to be economically viable compared with existing training methods such as animal labs, virtual reality platforms, and supervised proctoring on early cases. Each printed model requires high-quality imaging, segmentation expertise, specialized printers, and integration with pumps, sensors, and imaging systems, all of which add to per-case expense and turnaround time. Regulatory pathways are similarly unsettled: if a simulator directly informs procedural planning or device selection for an individual patient, it may fall under device regulations that demand rigorous validation. Until those cost, workflow, and regulatory questions are systematically studied and reported, beating printed hearts like the WSU model will remain powerful demonstrations of what is technically possible rather than standard fixtures in cardiac operating rooms.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
